• Part of Records of the Office of the Chief of Staff (Clinton Administration), Harold Ickes, Jr.'s Files

Read the transcription

Extracted text

OCR Page 1 of 9
THE WHITE HOUSE WASHINGTON November 21, 1994 MEMORANDUM FOR LEON PANETTA THROUGH: HAROLD ICKES FROM: JOEL KLEIN JACK GIBBONS CC: BILL GALSTON GEORGE STEPHANOPOULOS SUBJECT: Federal Funding for Human Embryo Research The National Institutes of Health is currently considering whether to engage in federal funding for embryo research. The issue has attracted considerable public attention. The decision is likely to be controversial. BACKGROUND 1. The research at issue involves the preimplantation human embryo, which exists from the time of fertilization until approximately 14 days later. This research is important to advances in fertility treatments, contraception, and treatment of certain cancers and genetic illnesses. Research may involve byproduct embryos (extra embryos created by in vitro fertilization for reproductive purposes) or created embryos (embryos created solely for research purposes). 2. Reagan/Bush Administrations The Reagan and Bush Administrations refused to fund in vitro fertilization research (which encompasses embryo research). 3. Clinton Administration - In June 1993, Congress, with bipartisan support, nullified regulatory barriers to in vitro fertilization research. NIH Director Harold Varmus responded by convening an ad hoc advisory panel to make recommendations regarding federal funding of embryo research. The panel is made up of highly respected scientists, academics, and ethicists. On September 29, 1994, after holding six public hearings throughout the year, the advisory panel recommended (1) that certain categories of embryo research be permitted, (2) that certain categories of embryo research warrant further consideration, and (3) that certain categories of embryo research not be permitted. The advisory panel emphasized that embryo research could